Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-039902

Options or other derivatives

  • President and CEO acquired 1,743 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KANE MATTHEW R. President and CEO 2020-08-21 Grant or award · Employee Stock Option (Right to Buy) +1,743 1,743 I: show line 1 in the form
Loading xslF345X03/doc4.xml…